SUPNSupernus Pharmaceuticals, Inc.

$42.68-7.3% 1Y

$42.68

$41.3152 weeks$57.00

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +25% year on year, but operating margin narrowing (−24.9 points).

1 good, 1 to watch, 1 without data

Revenue trend+25% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +8% a year.

Margin direction−24.9 points operating

Trailing-twelve-month operating margin, -15.9% now against 9.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SUPN growing?

Supernus Pharmaceuticals, Inc. has grown revenue 9.4% a year over three years and 7.8% a year over five.

+9.4%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +7.8%
Revenue growth, 5-year rate · +9.4% over three · growth has picked up over the last three years
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›